BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34296508)

  • 21. Plasma cell myeloma with unusual morphology--a series of 6 cases.
    Gupta R; Hussain N; Rahman K; Nityanand S
    Eur J Haematol; 2014 Aug; 93(2):165-70. PubMed ID: 24628605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.
    Rawstron AC; Owen RG; Davies FE; Johnson RJ; Jones RA; Richards SJ; Evans PA; Child JA; Smith GM; Jack AS; Morgan GJ
    Br J Haematol; 1997 Apr; 97(1):46-55. PubMed ID: 9136941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
    Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
    Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.
    Rawstron AC; Orfao A; Beksac M; Bezdickova L; Brooimans RA; Bumbea H; Dalva K; Fuhler G; Gratama J; Hose D; Kovarova L; Lioznov M; Mateo G; Morilla R; Mylin AK; Omedé P; Pellat-Deceunynck C; Perez Andres M; Petrucci M; Ruggeri M; Rymkiewicz G; Schmitz A; Schreder M; Seynaeve C; Spacek M; de Tute RM; Van Valckenborgh E; Weston-Bell N; Owen RG; San Miguel JF; Sonneveld P; Johnsen HE;
    Haematologica; 2008 Mar; 93(3):431-8. PubMed ID: 18268286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
    Flores-Montero J; de Tute R; Paiva B; Perez JJ; Böttcher S; Wind H; Sanoja L; Puig N; Lecrevisse Q; Vidriales MB; van Dongen JJ; Orfao A
    Cytometry B Clin Cytom; 2016 Jan; 90(1):61-72. PubMed ID: 26100534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry.
    Alaterre E; Raimbault S; Garcia JM; Rème T; Requirand G; Klein B; Moreaux J
    Cytometry B Clin Cytom; 2018 May; 94(3):484-492. PubMed ID: 28865180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders.
    Jain G; Das N; Gajendra S; Gangwar SP; Gupta R; Mallik S; Sharma A; Kumar L; Upadhyay AD
    Int J Lab Hematol; 2022 Oct; 44(5):837-845. PubMed ID: 36106595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).
    Otsuyama K; Asaoku H; Kawano MM
    Int J Hematol; 2006 Jan; 83(1):39-43. PubMed ID: 16443550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders.
    Raja KR; Kovarova L; Hajek R
    Br J Haematol; 2010 May; 149(3):334-51. PubMed ID: 20201947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates.
    Post SR; Post GR; Nikolic D; Owens R; Insuasti-Beltran G
    Cytometry B Clin Cytom; 2018 Sep; 94(5):602-610. PubMed ID: 29573142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Utility of 8-colours multiparameter flow cytometry immunophenotyping of plasma cells for the management of monoclonal gammopathy].
    Gressier M; Chaquin M; Lhermitte L; Asnafi V; Macintyre E; Brouzes C
    Ann Biol Clin (Paris); 2013; 71(3):313-23. PubMed ID: 23747669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma.
    Requirand G; Robert N; Boireau S; Vincent L; Seckinger A; Bouhya S; Ceballos P; Cartron G; Hose D; Klein B; Moreaux J
    Cytometry B Clin Cytom; 2019 May; 96(3):209-214. PubMed ID: 30417559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical Localization of Malignant Plasma Cells in Non-Viable Cell Area on Flow Cytometry Light-Scatter Dot Plot.
    Juranovic T; Harvey G; Johnson J; Zhang D; Plata MJ; Estalilla OC; Jelic TM
    Am J Case Rep; 2018 Aug; 19():1019-1024. PubMed ID: 30146632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing five diagnostic criteria for multiple myeloma: a retrospective study of 227 cases.
    Junxun L; Juan L; Xiuzhen T; Juan O; Bohuang Z; Junru L
    Tumori; 2014; 100(2):207-13. PubMed ID: 24852867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artifactual Kappa Light Chain Restriction of Marrow Hematogones: A Potential Diagnostic Pitfall in Minimal Residual Disease Assessment of Plasma Cell Myeloma Patients on Daratumumab.
    Jiang XY; Luider J; Shameli A
    Cytometry B Clin Cytom; 2020 Jan; 98(1):68-74. PubMed ID: 31313879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface Markers.
    Bansal R; Kimlinger T; Gyotoku KA; Smith M; Rajkumar V; Kumar S
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e48-e51. PubMed ID: 32873534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment.
    Smock KJ; Perkins SL; Bahler DW
    Arch Pathol Lab Med; 2007 Jun; 131(6):951-5. PubMed ID: 17550325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features.
    Grogan TM
    Semin Diagn Pathol; 2003 Aug; 20(3):211-25. PubMed ID: 14552432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric myeloma measurable residual disease testing in the era of targeted therapies.
    Ng DP
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():71-77. PubMed ID: 34288444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.